HEALTHCARE company Doctor Anywhere said on Wednesday (Dec 21) that it has raised an additional US$38.8 million in its Series C1 round led by Novo Holdings, with participation from existing investors including IHH Healthcare and Singapore’s EDBI.

The new round of financing will be used to fund the acquisition of Asian Healthcare Specialists, as well as to accelerate growth for the company, said Doctor Anywhere.

This comes after the group announced last Thursday that its vehicle had received 97.48 per cent of valid acceptances for its bid to take Catalist-listed Asian Healthcare Specialists private.

Lim Wai Mun, founder and chief executive of Doctor Anywhere, said the acquisition would strengthen the group’s capabilities and enable the delivery of “more integrated, holistic care and greater value” to its users.

The group continues to be on the lookout for opportunities and targeted acquisitions of critical healthcare assets across the region, said Lim.

“A more diversified and holistic range of integrated healthcare service offerings will enable Doctor Anywhere to deliver greater value and impact to elevate the region’s healthcare outcomes,” he added.

GET BT IN YOUR INBOX DAILY

Start and end each day with the latest news stories and analyses delivered straight to your inbox.

Sign UpVIEW ALL

Doctor Anywhere raised US$65.7 million in a Series C round in August last year. This brings the total capital raised to nearly US$140 million.